Allegretta, C.; D’Amico, E.; Manuti, V.; Avolio, C.; Conese, M.
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. Int. J. Mol. Sci. 2022, 23, 3829.
https://doi.org/10.3390/ijms23073829
AMA Style
Allegretta C, D’Amico E, Manuti V, Avolio C, Conese M.
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. International Journal of Molecular Sciences. 2022; 23(7):3829.
https://doi.org/10.3390/ijms23073829
Chicago/Turabian Style
Allegretta, Caterina, Emanuele D’Amico, Virginia Manuti, Carlo Avolio, and Massimo Conese.
2022. "Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders" International Journal of Molecular Sciences 23, no. 7: 3829.
https://doi.org/10.3390/ijms23073829
APA Style
Allegretta, C., D’Amico, E., Manuti, V., Avolio, C., & Conese, M.
(2022). Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. International Journal of Molecular Sciences, 23(7), 3829.
https://doi.org/10.3390/ijms23073829